STAAR Surgical Co. (STAA) Lines out Q4 2011 Expectations, Announces Regulatory Approval for Product Marketing in Japan
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it expects revenue for the fourth quarter ended December 31, 2010, to exceed $14.2 million. The company said it expects to announce its fourth quarter and full year 2010 results March 1, 2011. The company posted revenues for the full year at approximately $55 million, a 7-percent increase over 2009 revenues, driven by a 10-percent increase in revenues from its core ICL and IOL product lines. "Our estimated fourth-quarter revenues were driven by strong growth in the Visian ICL product lines, which achieved…